Clinical practice guideline for activated phosphatidyl inositol 3-kinase-delta syndrome in Japan
AbstractActivated phosphatidyl inositol 3-kinase-delta syndrome (APDS) due to gain-of-function variant in the class IA PI3K catalytic subunit p110δ (responsible gene: PIK3CD) was described in 2013. The disease is characterized by recurrent airway infections and bronchiectasis. It is associated with...
Main Authors: | Kunihiko Moriya, Kanako Mitsui-Sekinaka, Yujin Sekinaka, Akifumi Endo, Hirokazu Kanegane, Tomohiro Morio, Kohsuke Imai, Shigeaki Nonoyama |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-10-01
|
Series: | Immunological Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/25785826.2023.2210366 |
Similar Items
-
Activated phosphoinositide 3-kinase delta syndrome 1 and 2 (APDS 1 and APDS 2): similarities and differences based on clinical presentation in two boys
by: Marlena Ewertowska, et al.
Published: (2020-04-01) -
Successful Management of Neutropenia in a Patient with CD40 Ligand Deficiency by Immunoglobulin Replacement Therapy
by: Lida Atarod, et al.
Published: (2007-03-01) -
Case Report: Analysis of Preserved Umbilical Cord Clarified X-Linked Anhidrotic Ectodermal Dysplasia With Immunodeficiency in Deceased, Undiagnosed Uncles
by: Satoshi Inaba, et al.
Published: (2021-12-01) -
A simplified preparation of phosphatidyl inositol
by: Giuseppe Colacicco, et al.
Published: (1967-09-01) -
Liver abscesses and hyper IgM syndrome
by: Ira Shah, et al.
Published: (2013-01-01)